Zhao BB - Search Results

1

Expression of CCL18 gene in ovarian cancer and its impact on the biologic function of ovarian cancer cells.

Yang YZ, Zhang W, Zhao BB, Li L. Yang YZ, et al. Among authors: zhao bb. Int J Clin Exp Pathol. 2019 Jul 1;12(7):2572-2584. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31934085 Free PMC article.

2

[Biological effects of down-regulating of TIZ gene on ovarian cancer cells in vitro].

Zhao BB, Zhang W, Yang ZJ, Wang Q, Li L. Zhao BB, et al. Zhonghua Fu Chan Ke Za Zhi. 2012 Oct;47(10):781-6. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 23302738 Chinese.

3

Diagnosis and preoperative predictive value of serum HE4 concentrations for optimal debulking in epithelial ovarian cancer.

Yang Z, Luo Z, Zhao B, Zhang W, Zhang J, Li Z, Li L. Yang Z, et al. Oncol Lett. 2013 Jul;6(1):28-34. doi: 10.3892/ol.2013.1339. Epub 2013 May 8. Oncol Lett. 2013. PMID: 23946773 Free PMC article.

4

Discovery of microarray-identified genes associated with ovarian cancer progression.

Liu X, Gao Y, Zhao B, Li X, Lu Y, Zhang J, Li D, Li L, Yin F. Liu X, et al. Int J Oncol. 2015;46(6):2467-78. doi: 10.3892/ijo.2015.2971. Epub 2015 Apr 20. Int J Oncol. 2015. PMID: 25891226

5

The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer.

Yang ZJ, Zhao BB, Li L. Yang ZJ, et al. Among authors: zhao bb. J Ovarian Res. 2016 Sep 15;9(1):57. doi: 10.1186/s13048-016-0266-3. J Ovarian Res. 2016. Retraction in: J Ovarian Res. 2022 Jul 1;15(1):76. doi: 10.1186/s13048-022-01008-x PMID: 27629537 Free PMC article. Retracted.

6

Relationship between inter-α-trypsin inhibitor heavy chain 4 and ovarian cancer.

Huang M, Zhang W, Zhao B, Li L. Huang M, et al. Chin J Cancer Res. 2019 Dec;31(6):955-964. doi: 10.21147/j.issn.1000-9604.2019.06.11. Chin J Cancer Res. 2019. PMID: 31949397 Free PMC article.

7

Case Report: Niraparib as Maintenance Therapy in A Patient With Ovarian Carcinosarcoma.

Zhang JQ, Zhao BB, Wang MM, Li L. Zhang JQ, et al. Among authors: zhao bb. Front Oncol. 2021 Dec 6;11:603591. doi: 10.3389/fonc.2021.603591. eCollection 2021. Front Oncol. 2021. PMID: 34938651 Free PMC article.

8

Retraction Note: The significance of the change pattern of serum CA125 level for judging prognosis and diagnosing recurrences of epithelial ovarian cancer.

Yang ZJ, Zhao BB, Li L. Yang ZJ, et al. Among authors: zhao bb. J Ovarian Res. 2022 Jul 1;15(1):76. doi: 10.1186/s13048-022-01008-x. J Ovarian Res. 2022. PMID: 35773699 Free PMC article. No abstract available.

9

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer.

Pan Z, Luo Z, He H, Chen Y, Zhao B, Yang Z, Li L. Pan Z, et al. J Ovarian Res. 2023 Feb 23;16(1):44. doi: 10.1186/s13048-022-01055-4. J Ovarian Res. 2023. PMID: 36823642 Free PMC article.

10

Low expression of KCNN3 may affect drug resistance in ovarian cancer.

Liu X, Wei L, Zhao B, Cai X, Dong C, Yin F. Liu X, et al. Mol Med Rep. 2018 Aug;18(2):1377-1386. doi: 10.3892/mmr.2018.9107. Epub 2018 May 31. Mol Med Rep. 2018. PMID: 29901154 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters